Impact of Counterfeits on Parallel Trade Pharmaceutical Distribution Issues initiatives and insights for supply chain integrity

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Takeda Pharmaceuticals North America, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Takeda Pharmaceuticals North America, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • by MarketLine
  • July 2014
  • 63 pages

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Takeda ...

Industries: Pharmaceutical | Countries: North America

Global Vitamin and Provitamin Market to 2018 - Market Size, Growth, and Forecasts in Nearly 70 Countries

Global Vitamin and Provitamin Market to 2018 - Market Size, Growth, and Forecasts in Nearly 70 Countries

  • $ 2 488
  • Industry report
  • by MarketSizeInfo
  • July 2014

This is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market for vitamins and provitamins. The publication provides the market size, growth and forecasts at the global level as well as for the following countries: Argentina, Armenia, Australia, ...

Industries: Vitamin and Supplement | Countries: World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Azerbaijan, South Africa, Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Vietnam, Thailand, Pakistan, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt, North America, Peru, Oman

MarketVIEW - Meningitis ACWY vaccines

MarketVIEW - Meningitis ACWY vaccines

  • $ 4 495
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • July 2014
  • 85 pages

Gram-negative Neisseria meningitidis (N.men) is an important contributor to bacterial meningitis. Of the estimated 1.2 million cases which occur each year (WHO Figures), N.men is thought to be responsible for around 40% of the total where 5 main serogroups ACWY and B are responsible for the majority ...

Industries: Drug and Medication | Countries: World, United States, Europe, Chile, South America, Saudi Arabia, Africa, United Kingdom, South Korea, Brazil, France, Asia, Argentina, Indonesia, Colombia, Mexico, Spain, Italy, Greece, Germany, Austria, Pakistan, Malaysia, North America

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 3 500
  • Industry report
  • by GBI Research
  • June 2014
  • 112 pages

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business intelligence provider, has released its latest research report, “Glioblastoma Multiforme Therapeutics ...

Industries: Therapy | Countries: World, Germany, Japan, United States, Europe, North America, Canada, Spain, Italy, France, United Kingdom

OmniLytics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

OmniLytics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • May 2014
  • 15 pages

Summary OmniLytics, Inc. (OmniLytics) is a biotechnology company. The company develops natural solutions for infectious disease and pest control. It conducts research and develops bacteriophage solutions for pathogen control in agricultural, food and water, industrial, pharmaceutical, and defense markets. ...

Industries: Pharmaceutical | Countries: United States, North America, El Salvador, World

Prime Pharmaceutical Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Prime Pharmaceutical Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • May 2014
  • 15 pages

Summary Prime Pharmaceutical Corporation (Prime Pharmaceutical) is a privately held pharmaceutical company. It is principally engaged in the research and development of products for the treatment of psoriasis. The company developed Relieva, a safe and effective product that can be used on its own o ...

Industries: Pharmaceutical | Countries: Canada, United States, North America

Pharmasset, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmasset, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • May 2014
  • 25 pages

Summary Pharmasset, Inc. (Pharmasset.) is a health care pharmaceutical company. The company is engaged in discovering, producing and commercializing medicines to treat viral infections. The company focus on development of oral therapeutics used for the treatment of hepatitis B virus (HBV), hepatitis ...

Industries: Pharmaceutical | Countries: United States, North America

Medicis Pharmaceutical Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile, Global Data

Medicis Pharmaceutical Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile, Global Data

  • $ 250
  • Company report
  • by Global Data
  • May 2014
  • 37 pages

Summary Medicis Pharmaceutical Corporation (Medicis) is a specialty pharmaceutical company. It discovers, develops and markets pharmaceutical products for the treatment of dermatological and aesthetic conditions. The company provides a wide range of products addressing various conditions, including acne, ...

Industries: Pharmaceutical | Countries: World, United States, Israel, Canada, North America

Vitamin and Provitamin Markets in the World to 2018 - Market Size, Trends, and Forecasts

Vitamin and Provitamin Markets in the World to 2018 - Market Size, Trends, and Forecasts

  • $ 22 464
  • Industry report
  • by Global Research & Data Services
  • May 2014

The expansion of the global vitamin and provitamin industry is forecast to reach 2.6% p.a. in the coming years. Between 2007 and 2013 the market increased with an average annual growth of 8.0%. Currently, vitamin E accounts for 37.0% of the global demand while the remaining market share is divided between ...

Industries: Vitamin and Supplement | Countries: United States, World, Europe, Asia, South America, North America, Czech Republic, South Korea, Philippines, Netherlands, Singapore, Panama, Slovenia, Slovakia (slovak Republic), Belgium, Japan, India, China, Australia, Argentina, United Kingdom, Macedonia, Lithuania, Sri Lanka, Kazakhstan, Indonesia, Azerbaijan, South Africa, Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Mexico, Canada, Ukraine, Sweden, Spain, Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Austria, Vietnam, Thailand, Pakistan, Malaysia, Lebanon, Jordan, Georgia, Armenia, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt

Mold Inhibitors Market, By Type (Propionates, Sorbates, Benzoates, and Natamycin), By Application (Food, Feed, Paint, Pharmaceuticals, and Cosmetics) - Global Trends & Forecast to 2019

Mold Inhibitors Market, By Type (Propionates, Sorbates, Benzoates, and Natamycin), By Application (Food, Feed, Paint, Pharmaceuticals, and Cosmetics) - Global Trends & Forecast to 2019

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • May 2014
  • 212 pages

The mold inhibitors market is expected to grow at a CAGR of 2.9% from 2014 to 2019. The estimation is made on the basis of the increasing health awareness among consumers as mold causes allergies, asthma, nausea and other ailments. Mold inhibitors have major applications in the feed industry, in the ...

Industries: Drug and Medication | Countries: World, North America, Europe, China, Mexico, Canada, India, South Africa, Brazil, France, Germany, Japan, United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.